Piramal Pharma Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹179.42
Market cap
23,812 Cr
P/B
2.92
Dividend yield
0.1%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales1,749 Cr3,660 Cr5,619 Cr8,171 Cr1,951 Cr4,193 Cr2,204 Cr2,754 Cr1,934 Cr2,044 Cr2,140 Cr2,752 Cr
Operating expenses (approx.)1,578 Cr3,175 Cr4,836 Cr6,862 Cr1,727 Cr3,566 Cr1,854 Cr2,151 Cr1,748 Cr1,819 Cr1,942 Cr2,421 Cr
EBITDA171 Cr485 Cr783 Cr1,309 Cr224 Cr627 Cr350 Cr603 Cr186 Cr224 Cr198 Cr331 Cr
OPM %9.8%13.3%13.9%16.0%11.5%14.9%15.9%21.9%9.6%11.0%9.2%12.0%
Other income38 Cr88 Cr149 Cr175 Cr20 Cr81 Cr12 Cr42 Cr58 Cr66 Cr43 Cr46 Cr
Interest119 Cr228 Cr334 Cr448 Cr107 Cr215 Cr103 Cr104 Cr86 Cr82 Cr89 Cr83 Cr
Depreciation174 Cr358 Cr544 Cr741 Cr185 Cr377 Cr197 Cr243 Cr197 Cr203 Cr213 Cr218 Cr
Profit before tax-121 Cr-101 Cr-96 Cr120 Cr-67 Cr35 Cr50 Cr257 Cr-98 Cr-61 Cr-104 Cr29 Cr
Tax %7.0%-25.7%-36.9%134.8%-64.6%398.8%126.9%46.5%-2.7%-87.0%-40.7%176.1%
Net profit-99 Cr-94 Cr-83 Cr18 Cr-89 Cr-66 Cr4 Cr154 Cr-82 Cr-99 Cr-136 Cr-9 Cr
EPS (₹)₹-0.83₹-0.75₹-0.66₹0.14₹-0.67₹-0.50₹0.03₹1.16₹-0.62₹-0.75₹-1.03₹-0.07

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales7,082 Cr8,171 Cr9,151 Cr8,869 CrSign in for TTM
Operating expenses (approx.)6,460 Cr7,038 Cr7,572 Cr7,930 CrSign in for TTM
EBITDA621 Cr1,133 Cr1,580 Cr939 CrSign in for TTM
OPM %8.8%13.9%17.3%10.6%Sign in for TTM
Other income225 Cr175 Cr135 Cr213 CrSign in for TTM
Interest344 Cr448 Cr422 Cr341 CrSign in for TTM
Depreciation677 Cr741 Cr816 Cr831 CrSign in for TTM
Profit before tax-174 Cr120 Cr342 Cr-233 CrSign in for TTM
Tax %-38.0%134.8%94.7%-64.3%Sign in for TTM
Net profit-186 Cr18 Cr91 Cr-326 CrSign in for TTM
EPS (₹)₹-1.57₹0.14₹0.69₹-2.46Sign in for TTM
Dividend payout %—0.0%15.9%—Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026
Equity capital1,193 Cr1,323 Cr1,324 Cr1,327 Cr
Reserves5,580 Cr6,588 Cr6,801 Cr6,835 Cr
Borrowings5,505 Cr4,559 Cr1,506 Cr1,196 Cr
Other liabilities2,244 Cr2,842 Cr6,046 Cr8,607 Cr
Total liabilities14,523 Cr15,312 Cr15,678 Cr17,965 Cr
Fixed assets (net)3,363 Cr3,873 Cr4,176 Cr4,451 Cr
CWIP853 Cr566 Cr489 Cr799 Cr
Investments469 Cr180 Cr64 Cr193 Cr
Other assets4,835 Cr5,464 Cr5,797 Cr7,192 Cr
Total assets14,523 Cr15,312 Cr15,678 Cr17,965 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity484 Cr1,005 Cr892 Cr1,653 Cr
Cash from investing-1,339 Cr-434 Cr-477 Cr-826 Cr
Cash from financing818 Cr-422 Cr-441 Cr-39 Cr
Net cash flow-37 Cr148 Cr-26 Cr788 Cr
Free cash flow (OCF − Capex)-481 Cr293 Cr228 Cr763 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2023Mar 2024Mar 2025Mar 2026
ROCE %-0.5%3.2%7.9%1.1%
ROE %-2.8%0.2%1.1%-4.0%
Debtor days9295——
Inventory days364402409559
Days payable258284——
Cash conversion cycle198213409559
Debt / equity0.810.580.190.15
Current ratio1.261.251.541.51
Net debt / EBITDA8.553.710.72-0.0047

Compare with peers

Loading peers…